MONTVALE, N.J., Jan. 21 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. today announced that Tony Scullion, Chief Executive Officer of Memory Pharmaceuticals has been appointed to the Board of Directors of the Biotechnology Council of New Jersey (BCNJ) effective January 20, 2005. Mr. Scullion’s appointment was announced last evening at the BCNJ’s 11th Annual Meeting at Princeton University.
Mr. Scullion joins a strong team of industry leaders. Current board members include Donald Drakeman, Ph.D, President and CEO, Medarex, Inc.; Paul G. Thomas, President and CEO, LifeCell Corporation; and Elizabeth E. Tallett, President and CEO, Neuventis, Inc.
“I am honored to serve as a board member of this important organization which has a proven track record of supporting New Jersey’s large and growing biotechnology sector. I look forward to working with my fellow board members to help the BCNJ fulfill its mission to the life sciences industry,” said Tony Scullion, Chief Executive Officer, Memory Pharmaceuticals.
Debbie Hart, president of BCNJ, said, “We are delighted that Tony Scullion will be joining the Council. Mr. Scullion brings a wealth of experience to the Council with thirty years of experience in the pharmaceutical and biotechnology industries. We are certain that he will bring invaluable insight and resources to the board.”
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating central nervous system (CNS) disorders such as Alzheimer’s disease, depression, schizophrenia, vascular dementia, Mild Cognitive Impairment, and memory impairments associated with aging. For additional information, please visit our website at http://www.memorypharma.com/.
About BCNJ
The mission of the Biotechnology Council of New Jersey is to promote a business and public policy environment in the state of New Jersey and beyond that enhances the growth and prosperity of New Jersey’s biotechnology companies. BCNJ currently has 150 member companies. For more information, please visit the BCNJ website at http://www.biotechnj.org/.
Memory Pharmaceuticals Corp.
CONTACT: Joseph M. Donabauer, Vice President and Controller of MemoryPharmaceuticals Corp., +1-201-802-7245; or Fern Lazar, President of LazarPartners, Ltd., +1-212-867-1765, for Memory Pharmaceuticals Corp.
